NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69,924 | -68.8% | 99,479 | +0.4% | 0.00% | -100.0% |
| Q4 2022 | $223,930 | -29.8% | 99,084 | -0.8% | 0.00% | 0.0% |
| Q3 2022 | $319,000 | -14.9% | 99,835 | +1.2% | 0.00% | -33.3% |
| Q2 2022 | $375,000 | +336.0% | 98,673 | +517.6% | 0.00% | – |
| Q1 2022 | $86,000 | -60.4% | 15,977 | -0.6% | 0.00% | -100.0% |
| Q4 2021 | $217,000 | -96.2% | 16,067 | -94.9% | 0.00% | -96.7% |
| Q3 2021 | $5,684,000 | +2.3% | 316,476 | -2.3% | 0.03% | +57.9% |
| Q2 2021 | $5,556,000 | -15.8% | 323,803 | -1.9% | 0.02% | -17.4% |
| Q1 2021 | $6,601,000 | +20.0% | 330,051 | +2.0% | 0.02% | +15.0% |
| Q4 2020 | $5,502,000 | +1.2% | 323,632 | -1.3% | 0.02% | -23.1% |
| Q3 2020 | $5,439,000 | -29.4% | 327,835 | -1.4% | 0.03% | -29.7% |
| Q2 2020 | $7,701,000 | +25.8% | 332,492 | -3.1% | 0.04% | +8.8% |
| Q1 2020 | $6,124,000 | -20.0% | 343,101 | -3.3% | 0.03% | +13.3% |
| Q4 2019 | $7,655,000 | +457.5% | 354,662 | +370.6% | 0.03% | +400.0% |
| Q3 2019 | $1,373,000 | -48.8% | 75,371 | +0.0% | 0.01% | -40.0% |
| Q2 2019 | $2,681,000 | +11.8% | 75,362 | +5.6% | 0.01% | +11.1% |
| Q1 2019 | $2,397,000 | +2.0% | 71,341 | -0.2% | 0.01% | -10.0% |
| Q4 2018 | $2,349,000 | -36.4% | 71,470 | +18.0% | 0.01% | -16.7% |
| Q3 2018 | $3,692,000 | +41.2% | 60,570 | +13.1% | 0.01% | +33.3% |
| Q2 2018 | $2,614,000 | -83.1% | 53,537 | -63.3% | 0.01% | -83.3% |
| Q1 2018 | $15,512,000 | +118.3% | 145,979 | +22.7% | 0.05% | +134.8% |
| Q4 2017 | $7,105,000 | +150.1% | 118,976 | +0.5% | 0.02% | +130.0% |
| Q3 2017 | $2,841,000 | +29.9% | 118,366 | +5.8% | 0.01% | +25.0% |
| Q2 2017 | $2,187,000 | +8.2% | 111,890 | +29.9% | 0.01% | +14.3% |
| Q1 2017 | $2,021,000 | +67.0% | 86,104 | -12.7% | 0.01% | +40.0% |
| Q4 2016 | $1,210,000 | -99.9% | 98,588 | +1.1% | 0.01% | -28.6% |
| Q3 2016 | $1,675,170,000 | +20.7% | 97,507 | +0.0% | 0.01% | +16.7% |
| Q2 2016 | $1,387,482,000 | -1.0% | 97,504 | -4.3% | 0.01% | +20.0% |
| Q1 2016 | $1,401,000,000 | -14.5% | 101,897 | +4.8% | 0.01% | -28.6% |
| Q4 2015 | $1,638,000,000 | +155455.6% | 97,206 | +1.2% | 0.01% | +40.0% |
| Q3 2015 | $1,053,000 | -99.9% | 96,029 | +0.6% | 0.01% | 0.0% |
| Q2 2015 | $1,194,217,000 | +33.4% | 95,461 | +17.3% | 0.01% | +25.0% |
| Q1 2015 | $895,488,000 | -30.7% | 81,408 | -2.4% | 0.00% | -33.3% |
| Q4 2014 | $1,292,824,000 | +23.7% | 83,408 | -3.6% | 0.01% | +20.0% |
| Q3 2014 | $1,044,864,000 | -39.6% | 86,567 | -35.9% | 0.01% | -37.5% |
| Q2 2014 | $1,730,213,000 | +63.0% | 134,962 | +54.1% | 0.01% | +60.0% |
| Q1 2014 | $1,061,191,000 | +18.6% | 87,557 | +11.0% | 0.01% | +25.0% |
| Q4 2013 | $894,936,000 | +7.8% | 78,849 | -0.7% | 0.00% | -20.0% |
| Q3 2013 | $829,919,000 | -9.0% | 79,419 | +0.6% | 0.01% | 0.0% |
| Q2 2013 | $911,734,000 | – | 78,938 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |